Halozyme Therapeutics Inc
Closed
SectorHealthcare
70.38 0.23
Overview
Share price change
24h
Min
70.07
Max
71
Income | 292M 150M |
|---|---|
Sales | -75M 377M |
P/E Sector Avg | 24.818 49.052 |
EPS | 1.221 |
Profit margin | 39.832 |
Employees | 423 |
EBITDA | -63M 218M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +21.7% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | 740M 8.4B |
|---|---|
Previous open | 70.15 |
Previous close | 70.38 |
News Sentiment
By Acuity
25%
75%
62 / 344 Healthcare
Halozyme Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Halozyme Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 85.8 USD 21.7%
High 96 USD
Low 70 USD
Based on 5 Wall Street analysts offering 12 month price targets forHalozyme Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$